Want to track BSLN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Basilea Pharmaceutica Ltd (BSLN) Statistics
Valuation metrics
Market Cap 615.02M
Enterprise value 694.5M
Trailing P/E (ttm) 19.36
Forward P/E 12.28
PEG ratio -0.35
Price/Sales (ttm) 3.52
Price/Book (mrq) 4.89
Enterprise Value/Revenue 3.85
Enterprise Value/EBITDA 16.57
Overview
Shares outstanding 12.29M
Float 12.21M
Shares short -
% Held by insiders 0.01%
% Held by institutions 0.3%
Average volume (10 days) 29.14K
Average volume (90 days) 26.79K
Price summary
52-Week low 44.7
52-Week high 59.7
Beta 0.42
50-Day moving average 52.14
200-Day moving average 53.58
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 21 Jun 2013
Ex-Dividend Date 11 Apr 2013
Last split factor 1,039:1,029
Last split Date 13 Mar 2007
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.18%
Operating margin 0.22%
Operational effectiveness
Return on assets 0.11%
Return on equity 0.28%
Income Statement
Revenue (ttm) 232.38M
Revenue per share (ttm) 14.78
Quarterly revenue growth (yoy) -0.03%
Gross profit (ttm) 87.16M
EBITDA 51.05M
Net income to common (ttm) 40.24M
Diluted EPS (ttm) 2.65
Quarterly earnings growth (yoy) -0.57%
Balance Sheet
Total cash (mrq) 159.8M
Total cash per share (mrq) 13.3
Total debt (mrq) 89.22M
Total Debt/Equity (mrq) 0.7
Current ratio (mrq) 5.11%
Book value per share (mrq) 10.48
Cash Flow
Cash flow statement 62.09M
Levered free cash flow (LFCF) 49.16M
